Camras Vision is currently developing a glaucoma therapy that is intended to not only circumvent the complications present with glaucoma surgery, but also to provide ophthalmologists with the first tool that can stop the progression of glaucoma. The key innovation of the Camras Shunt is that it drains aqueous humor externally, thereby avoiding the complications and failure due to scarring within the drainage site that is associated with all other incisional/shunt surgeries.